# DaVita Inc. – Consensus ‘hold’ rating and 4.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/davita-inc.consensus-hold-rating-and-4.7-upside-potential/4121134695
- Published: 2023-11-30T14:01:36+00:00
- Author: Charlotte Edwards

**DaVita Inc.** which can be found using ticker (DVA) have now 6 analysts in total
covering the stock. The consensus rating is pointing to ‘hold’. The range between
the high target price and low target price is between $113.00 and $90.00 calculating
the mean target price we have $104.33. Given that the stocks previous close was 
at $99.67 and the analysts are correct then we can expect a percentage increase 
in value of 4.7%. The 50 day MA is $87.81 and the 200 day MA is $92.05. The total
market capitalization for the company now stands at 9.10B. The stock price is currently
at: $99.61 USD

 The potential market cap would be $9,524,599,295 based on the market consensus.

The company has a dividend yield of 3.8%. Other points of data to note are a P/E
ratio of 15.47, revenue per share of $131.29 and a 5.43% return on assets.

DaVita Inc. is a healthcare provider. The Company provides kidney care services 
in the United States. The Company’s operations are comprised of its U.S. dialysis
and related lab services business (its U.S. dialysis business), its U.S. integrated
kidney care business, its U.S. other ancillary services and its international operations(
its ancillary services). The U.S. dialysis and related lab services (U.S. dialysis)
business treats patients with chronic kidney failure, and end-stage kidney disease(
ESKD). Its services include outpatient hemodialysis services, hospital inpatient
hemodialysis services, and home-based dialysis services. The ancillary services 
consist of integrated kidney care services, physician services, clinical research
programs, and transplant software business, as well as international operations.
The Company operates approximately 2,724 outpatient dialysis centers in the United
States.

Share on:
